Unlock curative surgery
Selective internal radiation therapy (SIRT) in the setting of bridging or downstaging can promote HCC patient access to curative pathways.
"No surgical treatment was feasible at that time, they suggested SIRT – which would have reduced tumour size enough so that they could perform surgery to remove it” (Martyn, SIRT patient)
Hear about Martyn's story of hope!
Liver transplantation following Y-90 for HCC
A multidisciplinary team (MDT) has analysed the data of 207 HCC patients treated with Y-90 spheres for downstaging/bridging to liver transplant. Data showed extended survival and reduced disease recurrence in a 15-year follow up period time.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.
Content of this video is for Information Purposes only and does not constitute medical advice. BSC strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.
This material not intended for use in France. 2023 Copyright © Boston Scientific Corporation or its affiliates. All rights reserved.
TheraSphere is a registered trademark of Theragenics Corporation, used under license by Boston Scientific Medical Device Limited, a wholly owned indirect subsidiary of Boston Scientific Corporation.